(2S,3S,4S,5S,6S)-6-[(1R,2R,4S,5R,8S,10S,13S,14R,17S,18R,21R,22R,23S)-21-benzoyloxy-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-22-[(E)-3-phenylprop-2-enoyl]oxy-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosan-10-yl]-4-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid

Details

Top
Internal ID 7facd2d3-3839-4f34-85f5-a711cb5bde55
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name (2S,3S,4S,5S,6S)-6-[(1R,2R,4S,5R,8S,10S,13S,14R,17S,18R,21R,22R,23S)-21-benzoyloxy-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-22-[(E)-3-phenylprop-2-enoyl]oxy-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosan-10-yl]-4-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid
SMILES (Canonical) CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(C(OC3OC4C(C(OC(C4OC5C(C(C(C(O5)CO)O)O)O)C6CCC7(C(C6(C)C)CCC8(C7CCC91C8(CC(C2(C9CC(C(C2OC(=O)C=CC2=CC=CC=C2)OC(=O)C2=CC=CC=C2)(C)C)C(O1)O)O)C)C)C)C(=O)O)O)CO)O)O)C)O)O)O)O)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@H]2O[C@@H]3[C@H]([C@H]([C@H](O[C@H]3O[C@H]4[C@@H]([C@H](O[C@H]([C@@H]4O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)[C@H]6CC[C@@]7([C@H]8CC[C@]91[C@@H]2CC([C@H]([C@@H]([C@@]2([C@@H](C[C@]9([C@@]8(CC[C@H]7C6(C)C)C)C)O)[C@H](O1)O)OC(=O)/C=C/C1=CC=CC=C1)OC(=O)C1=CC=CC=C1)(C)C)C)C(=O)O)O)CO)O)O)C)O)O)O)O)O
InChI InChI=1S/C76H108O31/c1-32-44(81)48(85)52(89)65(96-32)103-58-50(87)45(82)33(2)97-67(58)104-59-51(88)47(84)38(31-78)99-68(59)102-56-54(91)57(63(92)93)101-55(60(56)105-66-53(90)49(86)46(83)37(30-77)98-66)36-22-25-72(7)39(71(36,5)6)23-26-73(8)40(72)24-27-75-41-28-70(3,4)61(106-64(94)35-18-14-11-15-19-35)62(100-43(80)21-20-34-16-12-10-13-17-34)76(41,69(95)107-75)42(79)29-74(73,75)9/h10-21,32-33,36-42,44-62,65-69,77-79,81-91,95H,22-31H2,1-9H3,(H,92,93)/b21-20+/t32-,33-,36+,37+,38+,39-,40+,41-,42+,44-,45-,46-,47-,48+,49-,50+,51-,52+,53+,54-,55-,56-,57-,58+,59+,60-,61-,62-,65-,66-,67-,68-,69-,72-,73+,74-,75-,76+/m0/s1
InChI Key LHLWERNEXPTXMR-AVSAADINSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C76H108O31
Molecular Weight 1517.60 g/mol
Exact Mass 1516.6874566 g/mol
Topological Polar Surface Area (TPSA) 486.00 Ų
XlogP 2.70
Atomic LogP (AlogP) -0.72
H-Bond Acceptor 30
H-Bond Donor 16
Rotatable Bonds 17

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2S,3S,4S,5S,6S)-6-[(1R,2R,4S,5R,8S,10S,13S,14R,17S,18R,21R,22R,23S)-21-benzoyloxy-2,23-dihydroxy-4,5,9,9,13,20,20-heptamethyl-22-[(E)-3-phenylprop-2-enoyl]oxy-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosan-10-yl]-4-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7911 79.11%
Caco-2 - 0.8584 85.84%
Blood Brain Barrier - 0.5750 57.50%
Human oral bioavailability - 0.8429 84.29%
Subcellular localzation Mitochondria 0.7928 79.28%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8014 80.14%
OATP1B3 inhibitior + 0.9107 91.07%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.7787 77.87%
BSEP inhibitior + 0.9708 97.08%
P-glycoprotein inhibitior + 0.7425 74.25%
P-glycoprotein substrate + 0.7044 70.44%
CYP3A4 substrate + 0.7501 75.01%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8733 87.33%
CYP3A4 inhibition - 0.6129 61.29%
CYP2C9 inhibition - 0.8242 82.42%
CYP2C19 inhibition - 0.8618 86.18%
CYP2D6 inhibition - 0.9436 94.36%
CYP1A2 inhibition - 0.9072 90.72%
CYP2C8 inhibition + 0.8567 85.67%
CYP inhibitory promiscuity - 0.9343 93.43%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.6047 60.47%
Eye corrosion - 0.9898 98.98%
Eye irritation - 0.8961 89.61%
Skin irritation - 0.7044 70.44%
Skin corrosion - 0.9395 93.95%
Ames mutagenesis - 0.6500 65.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7569 75.69%
Micronuclear - 0.7000 70.00%
Hepatotoxicity - 0.6834 68.34%
skin sensitisation - 0.9106 91.06%
Respiratory toxicity + 0.7333 73.33%
Reproductive toxicity + 0.8444 84.44%
Mitochondrial toxicity + 0.5625 56.25%
Nephrotoxicity - 0.9674 96.74%
Acute Oral Toxicity (c) I 0.6886 68.86%
Estrogen receptor binding + 0.5875 58.75%
Androgen receptor binding + 0.7646 76.46%
Thyroid receptor binding + 0.7571 75.71%
Glucocorticoid receptor binding + 0.8200 82.00%
Aromatase binding + 0.7299 72.99%
PPAR gamma + 0.8238 82.38%
Honey bee toxicity - 0.6210 62.10%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity + 0.5445 54.45%
Fish aquatic toxicity + 0.9925 99.25%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL221 P23219 Cyclooxygenase-1 99.03% 90.17%
CHEMBL1293249 Q13887 Kruppel-like factor 5 98.55% 86.33%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.73% 91.11%
CHEMBL4302 P08183 P-glycoprotein 1 97.53% 92.98%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.46% 96.09%
CHEMBL1951 P21397 Monoamine oxidase A 95.92% 91.49%
CHEMBL2581 P07339 Cathepsin D 93.84% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 92.31% 95.56%
CHEMBL3137262 O60341 LSD1/CoREST complex 91.67% 97.09%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 90.63% 96.00%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 90.19% 94.08%
CHEMBL216 P11229 Muscarinic acetylcholine receptor M1 89.95% 94.23%
CHEMBL5028 O14672 ADAM10 87.98% 97.50%
CHEMBL1806 P11388 DNA topoisomerase II alpha 87.62% 89.00%
CHEMBL3714130 P46095 G-protein coupled receptor 6 87.02% 97.36%
CHEMBL1994 P08235 Mineralocorticoid receptor 86.25% 100.00%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 86.17% 91.07%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 84.85% 93.00%
CHEMBL1293277 O15118 Niemann-Pick C1 protein 84.50% 81.11%
CHEMBL4227 P25090 Lipoxin A4 receptor 83.92% 100.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.70% 95.89%
CHEMBL1293294 P51151 Ras-related protein Rab-9A 83.61% 87.67%
CHEMBL226 P30542 Adenosine A1 receptor 83.53% 95.93%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 83.14% 95.83%
CHEMBL3060 Q9Y345 Glycine transporter 2 81.93% 99.17%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 80.93% 94.62%
CHEMBL218 P21554 Cannabinoid CB1 receptor 80.75% 96.61%
CHEMBL3475 P05121 Plasminogen activator inhibitor-1 80.55% 83.00%
CHEMBL3401 O75469 Pregnane X receptor 80.31% 94.73%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Maesa balansae

Cross-Links

Top
PubChem 102354529
LOTUS LTS0268973
wikiData Q105151838